bullish

Nexgel

IPO Databook: Nexgel (NXGL US) - Aug 2026

97 Views22 Aug 2026 10:09
SUMMARY
  • NexGel, Inc. manufactures high water content hydrogels for various applications, serving as a contract manufacturer and marketing branded consumer products, recently acquiring Celularity Inc.’s BioNx portfolio.
  • NexGel manufactures high water content hydrogels, specializing in custom gels using proprietary technologies. The company acquired Celularity Inc.’s BioNx portfolio on April 17, 2026, and operates two segments.
  • NexGel reported a net loss of $4.5 million and used $2.7 million cash in operations for the six months ended June 30, 2026, with substantial doubt about its ability to.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • IPO Databook: Nexgel (NXGL US) - Aug 2026
    22 Aug 2026
x